EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.8.3.1 | Acidosis, Lactic |
2265219 |
Clinical approach to inherited metabolic disorders in neonates. |
causal interaction
unassigned |
3
0 |
| 1.8.3.1 | arylsulfatase (type i) deficiency |
27106218 |
Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. |
causal interaction
unassigned |
4
0 |
| 1.8.3.1 | aspartate-ammonia ligase deficiency |
27106218 |
Antenatal manifestations of inborn errors of metabolism: autopsy findings suggestive of a metabolic disorder. |
causal interaction
unassigned |
4
0 |
| 1.8.3.1 | Asthma |
3302664 |
Adverse reactions to food additives. |
unassigned |
0 |
| 1.8.3.1 | Asthma |
33436091 |
A simulated patient study to evaluate community pharmacist assessment, management and advice giving to patients with asthma. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
2
1
0 |
| 1.8.3.1 | Brain Diseases |
23452914 |
Sulfite oxidase deficiency - An unusual late and mild presentation. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 1.8.3.1 | Brain Diseases |
24938149 |
Prenatal multicystic encephalopathy in isolated sulfite oxidase deficiency with a novel mutaion. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 1.8.3.1 | Brain Diseases |
28529047 |
Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency. |
causal interaction
unassigned |
4
0 |
| 1.8.3.1 | Carcinoma, Hepatocellular |
23665285 |
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
1
4
1
0 |
| 1.8.3.1 | Cardiovascular Diseases |
7131542 |
Nutrition education in supermarkets: an unsuccessful attempt to influence knowledge and product sales. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
